A Global Challenge in Numbers
The progress made in cell therapies to treat the most severe cases of diabetes marks a significant scientific milestone. However, it is important to recognize that while a few thousand transplantation of insulin-producing cells can be life-saving for individual patients, such interventions will have limited
M42, a global health leader powered by artificial intelligence (AI), technology and genomics, today announced the official incorporation of M42 Saudi Arabia, marking a new era in its partnership with the Kingdom.
The announcement was made during the Global Health Exhibition (GHE) in Riyadh, underscoring M42’s deepening commitment to
The Technology Innovation Institute (TII) announced that it currently has 70 patents in process across a wide range of advanced technology fields, an achievement that reflects the high output of its nine research centres.
The centres cover diverse and critical domains including artificial intelligence and digital science, autonomous
The University of Sharjah (UOS) continues to strengthen its international partnerships through a new collaboration with the global pharmaceutical leader Eli Lilly and Company (Lilly).
A high-level delegation from Lilly visited the university to discuss joint initiatives in public health, research, and education, reinforcing both
Researchers at the Girona Biomedical Research Institute (IDIBGI) and Pompeu Fabra University (UPF) in Barcelona, Spain, have identified a link between an amino acid and depression.
The compound, called proline, is found in common foods such as gelatin, beef and fish. The study, published in Cell Metabolism, suggests that diets rich in
